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Résumé 
L’analyse de la mortalité par cause repose principalement sur l’étude de la cause 
principale du décès. Notre point de vue est que cette approche n’est pas suffisante. 
Dans un nombre croissant de pays, toutes les causes reportées par les médecins 
sur les certificats de décès (ou «causes multiples») sont enregistrées et codées. Ces 
données peuvent être utilisées de deux façons principales : pour réévaluer le poids 
d’une cause particulière dans la mortalité ou pour examiner comment les causes 
sont associées les unes avec les autres. Dans cet article, nous nous appuyons sur 
une analyse des causes multiples de décès développée dans le cadre d’un projet 
comparatif franco-italien pour évaluer la qualité de ces données et pour montrer, 
tout particulièrement dans le contexte du vieillissement démographique, la perti-
nence de cette approche pour les politiques de santé publique. 
Mots-clés 
Mortalité, causes de décès, causes multiples, comparaisons transversales interna-
tionales, méthodes. 
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Summary 
Cause-specific mortality analysis is based predominantly on examination of the un-
derlying cause of death. Our view is that this single-cause approach is not suffi-
cient. With increasing data availability and technical developments in favor of bet-
ter data quality, the time has come to consider all items of information reported by 
certifying physicians on death certificates (i. e. the multiple causes). These data can 
be used in two main ways: either to reassess the role played by a given cause in 
mortality, or to examine how causes combine with one another. In this paper, we 
rely on our experience of multiple cause-of-death (MCOD) analysis in the frame-
work of a French-Italian comparative project to provide information on data quali-
ty, and to show that, especially in the context of population aging, MCOD analysis is 
a very relevant tool for public health policy.  
Keywords 
Mortality, causes of death, multiple causes, cross-country comparison, methods. 
In 1940 Theodore Janssen, the then Chief of the Nosology Section at the 
Division of Vital Statistics of the US Bureau of the Census wrote: «statis-
tics showing combinations of causes come nearer the truth than do those 
based on the single cause principle because the majority of deaths actually 
result from a combination of causes» (Janssen, 1940). So statisticians 
have long been aware of the idea that death often results from the con-
junction of several diseases, conditions or risk factors, but their main 
efforts have focused on producing tables that assign one single cause to 
each death and on ensuring quality and cross-country comparability for 
this underlying cause of death (UC). As we enter the 21st century, cause-
specific mortality analysis is still primarily conducted on the basis of the 
UC, but this does not mean that the multiple4 cause-of-death (MCOD) 
data have been entirely ignored. 
Firstly, the US, where MCOD data have been produced in electronic for-
mat since 1968, pioneered methodological research in this field. Follow-
ing Janssen’s recommendation, statisticians of the US National Center 
for Health Statistics (Guralnick, 1966) have proposed a number of me-
thods for tabulating and analysing multiple causes of death. Since then, a 
variety of indicators have been developed to describe the frequency of 
multiple-cause of death certificate entries and to investigate relations 
between contributing and underlying causes of death (for a review of 
these methods see Désesquelles et al., 2012). Secondly, a growing num-
ber of countries produce MCOD databases. 
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These developments encouraged us to engage in a comparative study 
using the French and Italian MCOD data. The French National Institute 
for Health and Medical Research (INSERM) has provided access to the 
complete information reported on the death certificates since 2000, si-
multaneously with the adoption of the 10th revision of the International 
Classification of Diseases (ICD-10) and the implementation of an auto-
matic coding system. In Italy, codes for all reported conditions have 
been available in databases since 1995, with the introduction of the au-
tomated coding system (Istat, 2004), but the first official release of 
MCOD data is for 2003, when the ICD-10 was adopted. Apart from data 
availability issues, one of the reasons why MCOD data has not been ana-
lysed as extensively as it could be is the widely shared scepticism about 
data quality. For this reason, much of our attention has been devoted to 
evaluating the quality of our data. In addition to that, we have improved 
existing indicators, specifically so that they can be used for cross-coun-
try comparisons. We first used this tool kit to produce results for France 
and Italy at quite aggregated levels of the ICD-10 (Désesquelles et al., 
2010), before focusing our attention on specific groups of causes (e. g. 
cancers, Alzheimer’s disease and Parkinson’s disease, and infectious di-
seases). 
This paper is the result of a critical and reflective exercise on our expe-
rience so far. We discuss the relative strengths and weaknesses of the 
MCOD approach on the basis of previous research findings. The paper 
has two main parts. We begin with an in-depth investigation of the data 
quality. We then address the question raised in the title of the paper: is 
the underlying cause of death sufficient? We give several reasons why 
we think that the multiple cause-of-death approach should be used 
alongside the underlying cause-of-death approach to analyse mortality. 
In the last part of the paper, we report on the main challenges that 
would confront the research community if this approach were to be 
adopted. 
What do we know about MCOD data quality? 
A two-step process 
The production of cause-of-death statistics relies on two steps that are 
both crucial for quality. First, the certifying physician reports on the 
certificate the chain of events leading to death. Second, this information 
Cause-specific mortality analysis: 
Is the underlying causes of death sufficient? 
 
122
is coded. A growing number of countries now use an automatic coding 
system. To our mind, this innovation represents a major advance to-
wards improved data quality. Human intervention is limited to prob-
lematic cases that cannot be processed automatically and, at least in 
theory, the WHO coding rules can be applied systematically and uni-
formly, irrespective of the coding agent or the country. 
Regarding certification problems, several questions need to be raised. 
Do the certifying physicians always report all the causes that directly led 
to death (part I of the international form recommended by the WHO5) as 
well as every «other significant conditions contributing to the death but 
not relating to the disease or condition causing it» (part II of the form)? 
Do they only report causes that actually contributed to the lethal pro-
cess? Do they always report the causes in the correct order and on the 
right part of the certificate? Is the same contributing cause equally re-
ported whatever the underlying cause? The answer to these questions is 
probably negative but the extent and direction of potential bias due to 
cases of misreporting is difficult to assess. 
The average number of entries on the death certificate: A quality indicator? 
It is sometimes suggested that the average number of entries on the 
death certificates is an indicator of the data quality (White et al., 1989). 
And indeed, some of our results support this line of interpretation. In a 
recently published paper (Désesquelles et al., 2012) we show that the 
average number of entries is higher when the death occurs in hospital6. 
Information available to the certifying physician is likely to be more 
complete when the death occurs in a medical facility. The fact that the 
average number of entries increases up to age 80 reflects the growing 
complexity of the clinical picture with age, but its decline at older ages 
may result from a less thorough description of the morbid process when 
death occurs at very old ages. So the average number of entries on the 
death certificates is obviously affected by data quality, but its variations 
may also reflect real differences in the morbid process (e. g. depending 
on the UC), so it would be hazardous to interpret this number as a pure 
unique indicator of quality. 
                                                 
5. See copy in appendix 1. 
6. This result is obtained after controlling for the decedent’s age group and un-
derlying cause of death. 
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Lessons from the cross-country comparison 
In the studies we have conducted so far (Désesquelles et al., 2010, 
2012), we compare France and Italy. The French and Italian cause-of-
death data are not fully comparable, but the data collection methods and 
the health and mortality profiles of the two countries are similar enough 
to ensure that their comparison is meaningful. The similarity of results 
for the two countries is striking. Figure 1 illustrates this point in a con-
densed way. It presents a broad comparison of the values7 of the Cause-
of-Death Association Indicator (CDAI) in France and in Italy. The CDAI 
(Désesquelles et al., 2010) is designed to identify the most frequent 
cause-of-death associations involving a specific (group of) diseases(s)8. 
It is computed as the ratio between: 
– the age-standardized prevalence at death of a combination between 
a contributing cause and an underlying cause among all deaths as-
signed to that underlying cause; 
– the age-standardized prevalence at death of the same contributing 
cause among all deaths. 
The Cause-of-Death Association Indicator is given by the following for-
mula: 
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x,cu d  = number of deaths observed at age x with underlying cause u and contributing cause c; 
xu d  = number of deaths observed at age x with cause u as underlying cause; 
dc,,x = total number of deaths observed at age x with cause c as contributing cause (regardless of 
underlying cause); 
 dx = total number of deaths observed at age x (regardless of underlying cause); 
xd  = standard number of deaths at age x.  
Standardization makes it possible to compare various UCs within a 
country, as well as a given UC across various countries. The results 
shown in Figure 1 were computed using standard death counts obtained 
                                                 
7. Data are for year 2003. 
8. For a comprehensive and critical presentation of the indicators that can be 
used to measure the frequency of combinations of causes, see Désesquelles et al., 2012. 
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by averaging the number of deaths in France and in Italy in 2003 by fi-
ve-year age groups.  
FIGURE 1 Comparison of the CDAIs of France and Italy. 
Deaths over the age of one, excluding deaths 
from external causes, France and Italy, 2003 
 
Horizontal axis: contributing cause. Vertical axis: underlying cause. See abbreviations in the ap-
pendix. Cells corresponding to CDAIs under (respectively over) 100 in both countries are light 
(respectively dark) grey. Cells corresponding to CDAI over 100 in France or Italy only are white. 
Data: France: Inserm mortality database / Italy: ISTAT mortality database. 
Assuming independence of causes, the numerator and the denominator 
of the CDAI should be equal. If a CDAI is significantly over 100, then the 
corresponding association is more frequent than expected. On Figure 1 
the cells of the table that results from the cross-matching of every un-
derlying and every contributing cause of death have been coloured ac-
cording to the values of the corresponding CDAIs in France and Italy. 
When the CDAI is under (respectively over) 100 in both countries, the 
corresponding cell on the graph is light (respectively dark) grey. When 
it is over 100 in France (respectively in Italy) only, it is white. Clearly, 
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grey (light and dark) is the dominant colour. We are inclined to inter-
pret this similarity as a positive signal for data quality. Unless a clear 
bias can be identified, similar findings reinforce each other’s credibility. 
But caution is obviously required, and we cannot rule out that similar 
bias in the two countries leads to similar results. 
Consistency with medical knowledge 
A third line of discussion with respect to MCOD data quality concerns 
consistency with medical knowledge. The paper we mentioned before 
(Désesquelles et al., 2012) includes an application of the MCOD ap-
proach to cancer-related mortality in France and Italy. On the basis of 
our detailed analysis of the causes that frequently contribute to cancer 
mortality we were able to classify them into five patterns of associa-
tions: 
– The UC results from the degeneration of the contributing cause (e. g. 
chronic liver disease as contributing cause of a liver cancer). Since 
the contributing cause preceded the cancer, one might expect it to be 
selected as the UC. But in some cases, the WHO rules preclude this 
option.  
– The contributing cause is a risk factor for the UC (e. g., specifically to 
France, alcohol and tobacco consumption as contributing causes of 
several cancers: lung, larynx, upper aero-digestive system, oesopha-
gus, and liver). 
– The contributing cause and the UC have a common cause. As an ex-
ample, tobacco use is likely to be the hidden element behind the fre-
quent association we find between bladder cancer and lung cancer. 
The link between cigarette smoking and bladder cancer is indeed 
well established (Sasco et al., 2004). 
– The contributing cause is a consequence or a complication of the UC. 
Not surprisingly, this is the most frequent situation. As an example, 
we suspect that bone metastases are involved in the frequent associ-
ation we find between diseases of the musculoskeletal system/con-
nective tissue (mainly: pathological fractures) and several malignant 
cancers (breast, prostate, as well as lymphoid, haematopoietic and 
related tissue). Though it is difficult to distinguish between the two, 
it should be noted that the contributing cause may be a consequence 
of the UC or of its therapy. The strong association between diseases 
of the blood and several anatomic cancer sites potentially illustrates 
the latter case. 
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– The contributing cause is a symptom of the UC (e. g. brain cancer 
combined with epilepsy). This category may be considered a particu-
lar case of the previous one. 
A sixth category can also be defined. Contributing causes may play a role 
as «background factors for other causes» (Manton, Stallard, 1982): when 
combined with another serious disease, the risk of dying increases, re-
flecting either «synergistic» or «additive» morbid processes (Speizer et 
al., 1977). Typically, this is the case for hypertension that has been iden-
tified by several authors as a frequent contributing cause of death 
(Dorn, Moriyama, 1964; Wing, Manton, 1981; Manton, Stallard, 1982; 
Stallard, 2002). 
Our ability to classify a given association in at least one of these catego-
ries – note that some associations may well belong to several – depends 
on the state-of-the-art of medical knowledge. In our opinion, the fact 
that, at least with regard to cancer mortality, most associations fit in 
with at least one category – and are therefore in line with medical know-
ledge – speaks in favour of good data quality. We must also acknowledge 
that some associations cannot be categorized in any of the proposed 
groups. In some cases we were able to find elements in the ongoing 
medical research literature that helped to classify the association. As an 
example, the associations we find between breast cancer and Alzhei-
mer’s disease in France and breast cancer and arthrosis in Italy echo 
recent research on potential shared mechanisms between breast cancer 
tumorigenesis on the one hand, and neurodegenerative processes, oxi-
dative stress and inflammation on the other (Staropoli, 2008; Pavlides et 
al., 2010; Hedskog et al., 2011). The fact that certifying physicians report 
associations that are not validated by medical knowledge could be in-
terpreted as a sign of inappropriate certification. However, since part II 
of the death certificate is for any condition that may have contributed to 
the death, we think that the reporting of these causes complies with 
WHO instructions.  
Finally, in all our studies, only very few associations cannot be classified 
into any of our six categories. Do the corresponding certificates reflect 
«over-reporting» practices? Or do they (even involuntarily) reveal real 
interactions – whatever the category they belong to – between the re-
ported causes? No doubt further investigation is needed before deciding 
to reject this second hypothesis. 
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Why analyse MCOD data? 
Besides enhanced data availability and quality – with scope for further 
improvement – there are several reasons for considering that cause-
specific mortality analysis should not be restricted to reporting the un-
derlying cause of death only, but should also consider all contributing 
causes. The hierarchical organization of causes of death (underlying 
cause/contributing causes) conveys the idea that: 
– one cause can be unambiguously selected as the UC among all the 
other causes reported on the death certificate, and that 
– it is the cause that should receive most attention in public health po-
licies designed to achieve further progress in mortality reduction. 
The underlying cause of death is not always certain 
It is important to bear in mind that the selection of the underlying cause 
is a complex decision-making process. In his editorial for the American 
Journal of Public Health, Glasser (Glasser, 1981) wrote: 
«the underlying cause takes on a seemingly sacrosanct monolithic posture. This 
appearance of certainty is deceiving, of course. The rules for cause of death cod-
ing are responsive to the complex chain of events. Here, too, arbitrary decisions 
are required». 
Huge efforts have been made to ensure the quality of the reporting and 
coding of the UC. These efforts suggest that the task is not an easy one. 
As mentioned before, the complexity of the pathological profiles of very 
old persons makes the choice of the underlying cause by the certifying 
physicians even trickier. So with increasing longevity, the reliability of 
the UC is likely to decrease.  
A handful of studies have tried to assess the reliability of UC selection. 
For a sample of 372 death certificates reporting ill-defined causes as UC 
or with at least one contributing cause, D’Amico (D’Amico et al., 1999) 
compared the assigned UC on the death certificate with the cause reat-
tributed after interviewing the certifying physician or examining clinical 
records. The initially assigned code differed from the modified code for 
54% of the ill-defined underlying causes and 55% of the certificates 
with multiple causes. In a study of 400 cardiac deaths (Mant et al., 
2006), pairs of clinicians were asked to assign the underlying cause of 
death independently of each other. They agreed on the cause of death in 
54% of cases only. The consensus decision of reviewers agreed with the 
death certificate diagnosis in 61.5% of the cases. In another study, 
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Tsung-Hsueh Lu (Tsung-Hsueh Lu et al., 2010) developed an algorithm 
to identify incorrect causal sequences on death certificates where diabe-
tes was reported in Part I. The frequency of incorrect statements in-
creased from 22% in 1985 to 35% in 2005. 
MCOD is a useful tool for prevention policies 
Regarding the idea that public health policies should focus on underly-
ing causes of death, we believe that interventions targeted at causes 
other than the UC could also reduce mortality. Our categorization of the 
associations of causes provides a useful framework to support this view. 
Risk factors for the UC as well as diseases/conditions that caused both 
the UC and a contributing cause can be the target of primary and sec-
ondary prevention. Contributing causes that are consequences/compli-
cations of the UC (or its therapy) are typically the focus of tertiary pre-
vention. As an example, in our study on Parkinson’s disease, Alzheimer’s 
disease and other dementias, we found that lung diseases due to exter-
nal agents (mainly: pneumonitis due to food and vomit), malnutrition 
and other nutritional deficiencies (mainly: unspecified protein-energy 
malnutrition), diseases of the skin and subcutaneous tissue (mainly: 
decubitus ulcer), «other diseases of the genitourinary system» (mainly: 
urinary tract infection) as well as pneumonia, frequently contribute to 
deaths from these diseases. All these causes reflect circumstances such 
as bed confinement, loss of autonomy, and frailty that often characterize 
the end of life of people affected by these diseases. Better care provision 
might eliminate some of these contributory factors, while at the same 
time improving patients’ quality of life. 
Reassessing the role of certain causes in mortality 
Finally, whatever their role in the process leading to death, there is a 
need to measure and monitor the weight of these contributing causes in 
overall mortality. For that purpose we compute the so-called «standard-
ized ratio of multiple to underlying cause» (SRMU) which is defined as 
the ratio between9: 
                                                 
9. For a comprehensive and critical presentation of the indicators that can be 
used to measure the frequency of multiple-cause death certificate entries, see 
Désesquelles et al., 2012. 
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– the age- and sex-standardized mortality rates for a given disease re-
ported as either underlying or contributing cause of death.  
– the age- and sex-standardized mortality rates for the same disease 
reported as UC. 
The SRMU measures the extent to which the role played by a disease in 
overall mortality is underestimated when the analysis is performed us-
ing the underlying cause only. It is low for diseases that are usually se-
lected as the UC and high for diseases that are rarely the UC. Table 1 dis-
plays the results for deaths in France and Italy at ages 65 and over. The 
highest values are for diseases of the skin and the subcutaneous tissues 
(7 in France and 15 in Italy), diseases of the blood (6 in France and 11 in 
Italy), diseases of the genitourinary system (5 in France and 9 in Italy), 
infectious and parasitic diseases (4 in France and 5 in Italy), and for 
endocrine, nutritional and metabolic diseases (4 in France and 4 in Ita-
ly). SRMU also has a value of 4 in Italy for «diseases of the musculoskele-
tal system/connective tissue» and for «diseases of the respiratory sys-
tem». So the role played by these groups of diseases in overall mortality 
is significantly underestimated. By contrast, most entries of a neoplasm 
are selected as the UC (SRMU in both countries is only slightly over 1). 
In our detailed analysis of cancer-related mortality (Désesquelles et al., 
2012), we show that most site-specific values of the SRMU are close to 
one. The most notable exception is for prostate cancer (1.4 in both coun-
tries). It may reflect the fact that prostate cancer is often diagnosed at 
advanced ages when people may have already developed other diseases. 
It may also indicate better survival chances for this cancer: 
«Better therapies for some diseases (ex: neoplasm) may result in death from 
another cause with the treated disease listed as contributing rather than under-
lying the death» (White, 1989). 
And indeed – and this is another example of the aforementioned «back-
ground factor» category –, though not directly causing the death, pros-
tate cancer may have contributed to it, either because the combinations 
of the cancer with another disease increased the patient’s vulnerability 
or because treatments were not compatible. 
Again, the results given in table 1 show that the causes whose weight in 
mortality is most severely underestimated when the UC only is consid-
ered, are common to both countries. However, it is also worth noting 
that the values of the SRMUs are almost always higher in Italy than in 
France. This result is obviously related to the fact that, on average, more 
causes are reported on the death certificates in Italy than in France (af-
ter excluding ill-defined mentions, 3.2 vs 2.5 for 2008). But it may also 
be that the propensity to select certain conditions as the underlying 
Cause-specific mortality analysis: 
Is the underlying causes of death sufficient? 
 
130
cause differs in the two countries. Typically, this may occur for degener-
ative diseases, which often result in complex morbid processes. In that 
case, cross-country comparison based on the underlying cause only will 
lead to erroneous conclusions. This strongly supports the argument for 
examining cross-country similarities and dissimilarities in the underly-
ing cause-of-death mortality rates in the light of results of MCOD analy-
sis. 
TABLE 1 Standardized mortality rates (per 100’000) for each cause reported 
as underlying cause (1) or multiple cause (2) and Standardized Ratio 
of Multiple to Underlying cause (2/1). 
Deaths at ages 65 and over, France and Italy, 2008 
Cause of death Italy France 
Underlying 
cause (1) 
Multiple 
cause (2) 
SRMU 
(2/1) 
Underlying 
cause (1) 
Multiple 
cause (2) 
SRMU 
(2/1) 
Infectious and parasitic diseases 46 232 5 62 263 4 
Neoplasms 1’084 1’239 1 987 1’107 1 
Diseases pf the blood (forming organs), im-
munological disorders 
15 175 11 13 81 6 
Endocrine, nutritional and metabolic diseases 155 606 4 121 437 4 
Mental and behavioral disorders 94 242 3 101 298 3 
Diseases of the nervous system 119 338 3 173 346 2 
Diseases of the circulatory system 1’409 2’303 2 900 1’472 2 
Diseases of the respiratory system 261 1’007 4 215 612 3 
Diseases of the digestive system 141 440 3 130 309 2 
Diseases of the skin and subcutaneous tissue 5 70 15 10 65 7 
Diseases of the musculoskeletal system/con-
nective tissue 
21 89 4 23 61 3 
Diseases of the genitourinary system 65 561 9 62 283 5 
Other diseases 2 18 7 2 12 6 
Symptoms, signs, abdominal findings, ill-defi-
ned causes and mechanisms of death 
79 - - 236 - - 
External causes 105 155 1 155 278 2 
Total 3’601 - - 3’035 - - 
Data: France: Inserm CépiDc mortality database; Italy: ISTAT mortality database. 
The multiple cause-of-death approach: 
challenges for the research community 
This last point supports our introductory statement that the single-cau-
se and the multiple-cause approach should not be considered as com-
peting but rather as complementary. The single-cause approach has pro-
ven to be a powerful tool for analysis of mortality trends and for cross-
country comparisons. The MCOD approach unquestionably provides a 
more detailed picture of how people die. As such, it is a useful tool for 
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understanding morbid processes leading to death and for implementing 
appropriate public health policies. But the method is still in its infancy. 
As mentioned above, efforts to improve data quality are needed, such as 
harmonization of death certificates, or better training of physicians in 
the specific problems of multiple-cause reporting. We are convinced 
that the growing use of the MCOD data by the research community will 
give the impetus for data collection improvements. In turn, the availabil-
ity of comparable indicators for a number of countries will provide new 
insights into data quality issues. 
In that perspective, methodological choices regarding the use of the 
MCOD data must be discussed widely within the scientific community. 
As an example, the way we compute the denominators of the CDAIs is 
not neutral: the leading causes of death contribute more to the value of 
the denominator than other causes of death. As a consequence, associa-
tions involving causes that frequently contribute to deaths due to a can-
cer or a disease of the circulatory system are less likely to emerge as 
strong associations. Other solutions should be explored10. A methodo-
logical choice must also be made about how to count entries that belong 
to the same subgroups of the – more or less detailed – aggregated list of 
causes. In our previous studies, these causes are counted only once to 
calculate the SRMUs. Similarly, for CDAIs, only one mention of a given 
group as contributing cause is considered in the computation11. Distinct 
ICD-10 codes that are considered «redundant» with an aggregated clas-
sification could of course be considered as different if a more detailed 
categorization were chosen. This implies that values of the indicators 
computed at different levels of the classification cannot be compared. 
One option is to compute all indicators at the lowest level of the ICD-10. 
Yet, while this solution looks nice on paper, it is largely impracticable for 
the production of readable tables and graphs. This said, we think there 
is a need to develop new visual tools and statistical methods. The analy-
sis we have conducted so far includes the computation of pairwise joint 
prevalences of every combination of underlying and contributing cause. 
This could be extended further to account for all the information report-
                                                 
10. One possible alternative consists in replacing the 
x
x,c
d
d  terms in the denomina-
tor by the average value, for the various UCs, of the 
xu
x,cu
d
d  terms. In fact, both formulas 
lead to very similar results (see Désesquelles et al., 2012). 
11. In cases where the underlying cause and the contributing cause belong to the 
same group, this association is counted once too. 
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ed on death certificates12. To achieve the objective that underpins our 
research – that of understanding more fully how people die – the huge 
amount of information we already process will inevitably increase. 
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Appendix 1. 
WHO recommended death certificate 
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Appendix 2. 
Abbreviations used for figure 1 
Multiple cause group Abbreviation 
Infectious and parasitic diseases INF 
Neoplasms NEO 
Diseases of the blood(-forming organs), immunol. disorders BLOOD 
Endocrine, nutritional and metabolic diseases ENDOC 
Mental and behavioural disorders MENT 
Diseases of the nervous system NERV 
Diseases of the circulatory system CIRC 
Diseases of the respiratory system RESP 
Diseases of the digestive system DIG 
Diseases of the skin and subcutaneous tissue SKIN 
Diseases of the musculoskeletal system/connective tissue MUS 
Diseases of the genitourinary system GEN 
Other diseases OTHER 
Symptoms, signs, abnormal findings, ill-defined causes ILLDEF 
External causes EXT 
 
